|
|
Thomson Financial Business Description:
| The Group's principal activities are identifying the underlying causes of, and discovering new treatments for asthma and chronic obstructive pulmonary disease. The Group aims to do this both in-house and via collaborations with industry partners, using advanced in vitro cell models of human disease. The Group operates predominantly in the United Kingdom. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Synairgen plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
